Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/1999
03/31/1999EP0905238A2 Pigrl-1, a member of immunoglobin gene superfamily
03/31/1999EP0905237A2 PIGR-2 A member of immunoglobulin gene superfamily
03/31/1999EP0905233A2 Staphylococcus aureus trigger factor
03/31/1999EP0904785A1 Protein C inhibitor against hypercoagulation
03/31/1999EP0904777A1 Use of an excitatory amino acids inhibitor in cosmetic or dermatological compositions for sensitive kin and composition obtained
03/31/1999EP0904539A1 Inhibiting protein interactions
03/31/1999EP0904373A1 Targeted delivery of genes encoding interferon
03/31/1999EP0904372A2 Human phospholipase inhibitor
03/31/1999EP0904349A1 Transgenic non-human mammals with progressive neurologic disease
03/31/1999EP0904299A1 Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides
03/31/1999EP0904289A1 Candida albicans tata-binding protein, nucleic acid and assays
03/31/1999EP0904283A1 Human netrin-1
03/31/1999EP0904281A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE
03/31/1999EP0904280A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE
03/31/1999EP0904278A1 Apoptosis inducing molecule ii
03/31/1999EP0904277A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
03/31/1999EP0904266A1 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
03/31/1999EP0904112A1 Composition comprising interleukin-1 inhibitor and controlled release polymer
03/31/1999EP0904110A1 Nitric oxide donors capable of reducing toxicity from drugs
03/31/1999EP0904108A1 METHODS FOR TREATMENT OF ALLERGIC DISEASES WITH IgE
03/31/1999EP0904105A1 Novel compounds
03/31/1999EP0904104A1 Novel compounds
03/31/1999EP0904097A2 Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest
03/31/1999EP0904094A1 Treatment of bone disorders with adrenomedullin
03/31/1999EP0904084A1 Emergency contraceptive kit
03/31/1999EP0904082A1 Combination therapy for reducing the risks associated with cardiovascular disease
03/31/1999EP0904079A1 Antidiabetic agents
03/31/1999EP0904078A1 COMPOSITION COMPRISING A Katp CHANNEL INHIBITOR FOR USE IN THE TREATMENT OF HEMORRHAGIC SHOCK
03/31/1999EP0904069A1 Pla2 inhibitors of angiogenesis
03/31/1999EP0904056A1 Process and device for inhalation of particulate medicaments
03/31/1999EP0750507A4 PROTEASOME REGULATION OF NF--g(k)B ACTIVITY
03/31/1999EP0660711B1 Novel use of inhibitors of phosphodiestersase iv
03/31/1999CN1212622A Use of antagnoist of PPAR-alpha and PPAR-gamma for treatment of syndrom X
03/31/1999CN1212620A Mercapto derivatives as inhibitors of cyclooxygenases
03/31/1999CN1212605A Composition and its use as food supplement or for lowering lipids in serum
03/31/1999CN1212149A Use of inhibitor of Na+/H+ exchanger for production of medicament
03/30/1999US5889171 Genetic engineered polypeptide
03/30/1999US5889145 Polynucleotides and polypeptides associated with benign prostatic hypertrophy
03/30/1999US5889143 Evaluation and treatment of patients with progressive immunosuppression
03/30/1999US5889054 Reducing the skin change associated with aging such as wrinkle, yellowing of skin, mottlling, leatheriness, loss of elasticity etc., comprising topically applying to the skin a wrinke or aging resistance beta-hydroxy acid
03/30/1999US5889052 Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
03/30/1999US5889038 Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
03/30/1999US5889033 Famotidine a histamine h2-antagonist is used to amelilorate apathy-amotivation syndrome and second set of psychologiacal disorders treating agents are psychostimulants, muscarinic agents, acetyl-cholinesterase inhibitors and notropics
03/30/1999US5889020 Treatment of normotensive glaucoma with angiotensin II antagonists
03/30/1999US5889006 Muscarinic antagonists
03/30/1999US5888990 Phosphocholine drug derivatives
03/30/1999US5888988 Wound healing agent
03/30/1999US5888963 Treatment of bone disorders with adrenomedullin
03/30/1999US5888771 Gene products as targets for the development of antibiotics.
03/30/1999US5888751 Method for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells
03/30/1999US5888523 Topical non-steroidal anti-inflammatory drug composition
03/30/1999US5888520 Composition, barrier film, and method for preventing contact dermatitis
03/25/1999WO1999014343A1 Dna encoding a ras carboxyl-terminal processing protein
03/25/1999WO1999014328A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999WO1999014321A1 Novel therapeutic molecules
03/25/1999WO1999014242A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999WO1999014239A1 Composition for treating diabetes mellitus and obesity
03/25/1999WO1999013923A2 Hydrogel wound dressing and the method of making and using the same
03/25/1999WO1999013915A1 Method of delivering genes to antigen presenting cells of the skin
03/25/1999WO1999013913A2 High viscosity liquid controlled delivery system as a device
03/25/1999WO1999013912A1 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
03/25/1999WO1999013911A1 Nootropic agent
03/25/1999WO1999013909A1 Corneal neovascularization inhibitors
03/25/1999WO1999013886A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications
03/25/1999WO1999013878A1 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST
03/25/1999WO1999013863A1 Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent
03/25/1999WO1999013799A1 Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
03/25/1999WO1999001463A3 Modified glycosides, compositions comprised thereof and methods of use thereof
03/25/1999WO1999000494A3 Cell activation process and reagents therefor
03/25/1999WO1998047518A9 Use of cholesterol-lowering agents to influence signal transduction processes in the cell membrane and in the prophylaxis or treatment of prion-associated diseases or alzheimer's disease
03/25/1999WO1998042296A3 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions
03/25/1999CA2382376A1 Novel polypeptides and nucleic acids encoding pro287 which are useful for treating disorders of the pancreas
03/25/1999CA2304312A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications
03/25/1999CA2304309A1 Dna encoding a ras carboxyl-terminal processing protein
03/25/1999CA2304124A1 Bci-2-like protein bim and methods of use thereof
03/25/1999CA2303834A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2303442A1 High viscosity liquid controlled delivery system as a device
03/25/1999CA2303178A1 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
03/25/1999CA2302782A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999CA2302316A1 Method of delivering genes to antigen presenting cells of the skin
03/25/1999CA2302204A1 A combination of a monoamine oxidase inhibitor and a h5-ht1b antagonist or partial agonist
03/25/1999CA2301782A1 Nootropic agent
03/25/1999CA2244978A1 Novel alcohol dehydrogenase
03/25/1999CA2244971A1 Mure
03/25/1999CA2244967A1 Murf
03/25/1999CA2244954A1 Murf
03/24/1999EP0903151A1 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
03/24/1999EP0903150A1 Regulation of immunoglobulin production by interleukin-9
03/24/1999EP0903145A2 Pharmaceutical composition for skin disorders
03/24/1999EP0902839A1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells
03/24/1999EP0902791A1 Extracellular/epidermal growth factor hcaba58x
03/24/1999EP0902624A1 Composition and its use as a food supplement or for lowering lipids in serum
03/24/1999EP0480950B1 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
03/24/1999CN1211985A Fused imidazole derivatives as multidrug resistance modulators
03/24/1999CN1211924A Immunomodulatory complex for helicobacter bacteria
03/24/1999CA2247733A1 The use of an inhibitor of the na+/h+ exchanger for the production of a medicament for the treatment or prophylaxis of disturbances of the central nervous system
03/23/1999US5886145 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
03/23/1999US5886054 Administering to a patient effective doses of scleroglucan and xanthane gum, in combination with electrolyte and preservative; saliva or tears substitute
03/23/1999US5886042 Amphoteric compostion and polymeric forms of alpha hydroxyacids, and their therapeutic use
03/23/1999US5886041 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
1 ... 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 ... 1151